Concepedia

Publication | Open Access

Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA)

122

Citations

11

References

2015

Year

References

YearCitations

Page 1